Brent L. Larson
2013
In 2013, Brent L. Larson earned a total compensation of $593K as Executive Vice President and Chief Financial Officer at Navidea Biopharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $51,013 |
|---|---|
| Option Awards | $260,387 |
| Salary | $274,717 |
| Other | $6,847 |
| Total | $592,964 |
Larson received $274.7K in salary, accounting for 46% of the total pay in 2013.
Larson also received $51K in non-equity incentive plan, $260.4K in option awards and $6.8K in other compensation.
Rankings
In 2013, Brent L. Larson's compensation ranked 8,759th out of 12,286 executives tracked by ExecPay. In other words, Larson earned more than 28.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,759 out of 12,286 | 29th |
Division Manufacturing | 3,190 out of 4,612 | 31st |
Major group Chemicals And Allied Products | 1,016 out of 1,466 | 31st |
Industry group Drugs | 775 out of 1,160 | 33rd |
Industry In Vitro and In Vivo Diagnostic Substances | 33 out of 56 | 41st |
Source: SEC filing on July 1, 2016.
Larson's colleagues
We found four more compensation records of executives who worked with Brent L. Larson at Navidea Biopharmaceuticals in 2013.
2013
Mark Pykett
Navidea Biopharmaceuticals
Chief Executive Officer
2013
Thomas Tulip
Navidea Biopharmaceuticals
President and Chief Business Officer
2013
Cornelia Reininger
Navidea Biopharmaceuticals
Chief Medical Officer
2013
Frederick Cope
Navidea Biopharmaceuticals